Barton Haynes (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Barton Haynes" in English language version.

refsWebsite

Global rank English rank

15nih.gov

4^th place

9web.archive.org

1^st place

6doi.org

2^nd place

1sciencemag.org

857^th place

3,832^nd place

1semanticscholar.org

11^th place

8^th place

1cavd.org

low place

1chavi.org

low place

1aegis.com

low place

1duke.edu

1,880^th place

1,218^th place

1archive-it.org

910^th place

593^rd place

1unctv.org

low place

1idsociety.org

low place

1aai.org

low place

aai.org

American Association of Immunologists. 2013 AAI Award Recipients Archived 2013-03-20 at the Wayback Machine.

aegis.com

Simon Noble. "An Interview with Barton Haynes: A new virtual Center Archived June 4, 2011, at the Wayback Machine." IAVI Report. 2005 Sep/Oct 9(4);4

archive-it.org

wayback.archive-it.org

Duke Human Vaccine Institute. About the Institute Archived March 4, 2011, at Archive-It.

cavd.org

Collaboration for AIDS Vaccine Discovery. About the Grantees.

chavi.org

Center for HIV/AIDS Vaccine Immunology. Progress Reports Archived August 25, 2013, at the Wayback Machine.

doi.org

Cohen, Jon (2006). "Gates Foundation Doubles Support for AIDS Vaccine Research". Science. 313 (5785): 283. doi:10.1126/science.313.5785.283a. PMID 16857908. S2CID 6506698.
Haynes, BF; Gilbert, PB; McElrath, MJ; Zolla-Pazner, S; Tomaras, GD; Alam, SM; Evans, DT; Montefiori, DC; Karnasuta, C; Sutthent, R; et al. (2012). "Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial". N. Engl. J. Med. 366 (14): 1275–86. doi:10.1056/NEJMoa1113425. PMC 3371689. PMID 22475592.
Haynes, BF; Kelsoe, G; Harrison, SC; Kepler, TB (2012). "B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study". Nat. Biotechnol. 30 (5): 423–33. doi:10.1038/nbt.2197. PMC 3512202. PMID 22565972.
Bonsignori, Mattia (March 2, 2016). "Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody". Cell. 165 (2): 449–63. doi:10.1016/j.cell.2016.02.022. PMC 4826291. PMID 26949186.
Haynes, Barton (March 9, 2016). "HIV-Host Interactions: Implications for Vaccine Design". Cell Host Microbe. 19 (3): 292–303. doi:10.1016/j.chom.2016.02.002. PMC 4823811. PMID 26922989.
Verkoczy, Laurent (May 9, 2014). "AIDS/HIV. Host controls of HIV neutralizing antibodies". Science. 344 (6184): 588–589. doi:10.1126/science.1254990. PMC 4162091. PMID 24812389.

duke.edu

humanvaccine.duke.edu

Duke Human Vaccine Institute. About the Institute Archived March 4, 2011, at Archive-It.

idsociety.org

Infectious Diseases Society of America. Alexander Fleming Award Winners Archived 2012-07-23 at the Wayback Machine.

nih.gov

pubmed.ncbi.nlm.nih.gov

Cohen, Jon (2006). "Gates Foundation Doubles Support for AIDS Vaccine Research". Science. 313 (5785): 283. doi:10.1126/science.313.5785.283a. PMID 16857908. S2CID 6506698.
Haynes, BF; Gilbert, PB; McElrath, MJ; Zolla-Pazner, S; Tomaras, GD; Alam, SM; Evans, DT; Montefiori, DC; Karnasuta, C; Sutthent, R; et al. (2012). "Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial". N. Engl. J. Med. 366 (14): 1275–86. doi:10.1056/NEJMoa1113425. PMC 3371689. PMID 22475592.
Haynes, BF; Kelsoe, G; Harrison, SC; Kepler, TB (2012). "B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study". Nat. Biotechnol. 30 (5): 423–33. doi:10.1038/nbt.2197. PMC 3512202. PMID 22565972.
Bonsignori, Mattia (March 2, 2016). "Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody". Cell. 165 (2): 449–63. doi:10.1016/j.cell.2016.02.022. PMC 4826291. PMID 26949186.
Haynes, Barton (March 9, 2016). "HIV-Host Interactions: Implications for Vaccine Design". Cell Host Microbe. 19 (3): 292–303. doi:10.1016/j.chom.2016.02.002. PMC 4823811. PMID 26922989.
Verkoczy, Laurent (May 9, 2014). "AIDS/HIV. Host controls of HIV neutralizing antibodies". Science. 344 (6184): 588–589. doi:10.1126/science.1254990. PMC 4162091. PMID 24812389.

ncbi.nlm.nih.gov

Haynes, BF; Gilbert, PB; McElrath, MJ; Zolla-Pazner, S; Tomaras, GD; Alam, SM; Evans, DT; Montefiori, DC; Karnasuta, C; Sutthent, R; et al. (2012). "Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial". N. Engl. J. Med. 366 (14): 1275–86. doi:10.1056/NEJMoa1113425. PMC 3371689. PMID 22475592.
Haynes, BF; Kelsoe, G; Harrison, SC; Kepler, TB (2012). "B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study". Nat. Biotechnol. 30 (5): 423–33. doi:10.1038/nbt.2197. PMC 3512202. PMID 22565972.
Bonsignori, Mattia (March 2, 2016). "Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody". Cell. 165 (2): 449–63. doi:10.1016/j.cell.2016.02.022. PMC 4826291. PMID 26949186.
Haynes, Barton (March 9, 2016). "HIV-Host Interactions: Implications for Vaccine Design". Cell Host Microbe. 19 (3): 292–303. doi:10.1016/j.chom.2016.02.002. PMC 4823811. PMID 26922989.
Verkoczy, Laurent (May 9, 2014). "AIDS/HIV. Host controls of HIV neutralizing antibodies". Science. 344 (6184): 588–589. doi:10.1126/science.1254990. PMC 4162091. PMID 24812389.

www3.niaid.nih.gov

National Institute of Allergy and Infectious Diseases. Center for HIV/AIDS Vaccine Immunology. Questions and Answers Archived August 30, 2009, at the Wayback Machine.
James Hadley. "HHS Secretary Names Five to NIAID Advisory Council Archived August 30, 2009, at the Wayback Machine." National Institute of Allergy and Infectious Diseases. Feb. 26, 1999

niaid.nih.gov

National Institutes of Health." NIH Awards $31 Million for HIV/AIDS Vaccine Immunology and Immunogen Discovery." Press Release. July 11, 2012.

nih.gov

National Institutes of Health. "NIAID Funds Center for HIV/AIDS Vaccine Immunology (CHAVI) Archived August 2, 2009, at the Wayback Machine." Press Release. July 14, 2005.

sciencemag.org

Cohen, Jon (2006). "Gates Foundation Doubles Support for AIDS Vaccine Research". Science. 313 (5785): 283. doi:10.1126/science.313.5785.283a. PMID 16857908. S2CID 6506698.

semanticscholar.org

api.semanticscholar.org

Cohen, Jon (2006). "Gates Foundation Doubles Support for AIDS Vaccine Research". Science. 313 (5785): 283. doi:10.1126/science.313.5785.283a. PMID 16857908. S2CID 6506698.

unctv.org

UNC-TV. The New Age of HIV/AIDS. Interview: Bart Haynes, M.D. Archived April 6, 2009, at the Wayback Machine

web.archive.org

National Institutes of Health. "NIAID Funds Center for HIV/AIDS Vaccine Immunology (CHAVI) Archived August 2, 2009, at the Wayback Machine." Press Release. July 14, 2005.
National Institute of Allergy and Infectious Diseases. Center for HIV/AIDS Vaccine Immunology. Questions and Answers Archived August 30, 2009, at the Wayback Machine.
Center for HIV/AIDS Vaccine Immunology. Progress Reports Archived August 25, 2013, at the Wayback Machine.
Simon Noble. "An Interview with Barton Haynes: A new virtual Center Archived June 4, 2011, at the Wayback Machine." IAVI Report. 2005 Sep/Oct 9(4);4
UNC-TV. The New Age of HIV/AIDS. Interview: Bart Haynes, M.D. Archived April 6, 2009, at the Wayback Machine
James Hadley. "HHS Secretary Names Five to NIAID Advisory Council Archived August 30, 2009, at the Wayback Machine." National Institute of Allergy and Infectious Diseases. Feb. 26, 1999
Infectious Diseases Society of America. Alexander Fleming Award Winners Archived 2012-07-23 at the Wayback Machine.
American Association of Immunologists. 2013 AAI Award Recipients Archived 2013-03-20 at the Wayback Machine.
Duke University Medical Center Office of Publications. "Haynes Elected to Academy." Inside DUMC 2002-09: May 07, 2007 Volume 16 No. 9